{"id":"https://openalex.org/W2102690771","doi":"https://doi.org/10.1086/504693","title":"HIV\u20101 Coreceptor Use in Triple\u2010Class Treatment\u2013Experienced Patients: Baseline Prevalence, Correlates, and Relationship to Enfuvirtide Response","display_name":"HIV\u20101 Coreceptor Use in Triple\u2010Class Treatment\u2013Experienced Patients: Baseline Prevalence, Correlates, and Relationship to Enfuvirtide Response","publication_year":2006,"publication_date":"2006-06-21","ids":{"openalex":"https://openalex.org/W2102690771","doi":"https://doi.org/10.1086/504693","mag":"2102690771","pmid":"https://pubmed.ncbi.nlm.nih.gov/16779731"},"language":"en","primary_location":{"id":"doi:10.1086/504693","doi":"https://doi.org/10.1086/504693","is_oa":false,"landing_page_url":"https://doi.org/10.1086/504693","pdf_url":null,"source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031035471","display_name":"Tom Melby","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Tom Melby","raw_affiliation_strings":["Trimeris, Morrisville, NC 27560, USA. tmelby@trimeris.com","Trimeris, Morrisville, North Carolina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trimeris, Morrisville, NC 27560, USA. tmelby@trimeris.com","institution_ids":[]},{"raw_affiliation_string":"Trimeris, Morrisville, North Carolina;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077821126","display_name":"Michael DeSpirito","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael DeSpirito","raw_affiliation_strings":["Trimeris, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trimeris, Morrisville, North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108414829","display_name":"Ralph A. DeMasi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ralph DeMasi","raw_affiliation_strings":["Trimeris, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trimeris, Morrisville, North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035336361","display_name":"Gabrielle Heilek\u2010Snyder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabrielle Heilek\u2010Snyder","raw_affiliation_strings":["Roche Biosciences, Palo Alto, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Biosciences, Palo Alto, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075185353","display_name":"Michael Greenberg","orcid":"https://orcid.org/0000-0003-0014-7670","observed_orcids":["https://orcid.org/0000-0003-0014-7670"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael\u00a0L. Greenberg","raw_affiliation_strings":["Trimeris, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trimeris, Morrisville, North Carolina","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077395512","display_name":"Neil M.H. Graham","orcid":"https://orcid.org/0000-0002-1236-2311","observed_orcids":["https://orcid.org/0000-0002-1236-2311"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil Graham","raw_affiliation_strings":["Trimeris, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trimeris, Morrisville, North Carolina","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5031035471"],"corresponding_institution_ids":[],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":11.0288,"has_fulltext":true,"cited_by_count":114,"citation_normalized_percentile":{"value":0.98969136,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"194","issue":"2","first_page":"238","last_page":"246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.023900000378489494,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enfuvirtide","display_name":"enfuvirtide","score":0.9020000100135803},{"id":"https://openalex.org/keywords/r5-tropic-hiv-1","display_name":"R5-tropic HIV-1","score":0.628000020980835},{"id":"https://openalex.org/keywords/x4-tropic-hiv-1","display_name":"X4-tropic HIV-1","score":0.9800000190734863},{"id":"https://openalex.org/keywords/treatment-experienced-patients","display_name":"treatment-experienced patients","score":0.7580000162124634},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8510000109672546},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.9750000238418579},{"id":"https://openalex.org/keywords/virological-response","display_name":"virological response","score":0.8230000138282776},{"id":"https://openalex.org/keywords/immune-response","display_name":"immune response","score":0.9459999799728394},{"id":"https://openalex.org/keywords/ccr5","display_name":"CCR5","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C2778037500","wikidata":"https://www.wikidata.org/wiki/Q423327","display_name":"Enfuvirtide","level":5,"score":0.9884760975837708},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5558458566665649},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5443335175514221},{"id":"https://openalex.org/C2778899366","wikidata":"https://www.wikidata.org/wiki/Q421369","display_name":"Maraviroc","level":3,"score":0.527050256729126},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.4942221939563751},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47275763750076294},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4580047130584717},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4235064685344696},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4120629131793976},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3804255425930023},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2865011394023895},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.27626094222068787},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.2428400218486786},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.13180488348007202},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.0826573371887207},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.0674055814743042}],"mesh":[{"descriptor_ui":"D000077560","descriptor_name":"Enfuvirtide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015728","descriptor_name":"Receptors, HIV","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1086/504693","doi":"https://doi.org/10.1086/504693","is_oa":false,"landing_page_url":"https://doi.org/10.1086/504693","pdf_url":null,"source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:16779731","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16779731","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of infectious diseases","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1517417834","https://openalex.org/W1551243371","https://openalex.org/W1723922714","https://openalex.org/W1909719355","https://openalex.org/W1966066839","https://openalex.org/W1966261980","https://openalex.org/W1981292246","https://openalex.org/W1995205657","https://openalex.org/W1995355944","https://openalex.org/W1998859554","https://openalex.org/W2009692900","https://openalex.org/W2017592356","https://openalex.org/W2023155031","https://openalex.org/W2023270608","https://openalex.org/W2030648131","https://openalex.org/W2033757712","https://openalex.org/W2040506631","https://openalex.org/W2048336729","https://openalex.org/W2050839471","https://openalex.org/W2053624248","https://openalex.org/W2059627765","https://openalex.org/W2079517309","https://openalex.org/W2083377018","https://openalex.org/W2083413245","https://openalex.org/W2092279499","https://openalex.org/W2099172313","https://openalex.org/W2108256128","https://openalex.org/W2109097720","https://openalex.org/W2114279162","https://openalex.org/W2116789308","https://openalex.org/W2117798874","https://openalex.org/W2121538004","https://openalex.org/W2129106897","https://openalex.org/W2133649749","https://openalex.org/W2144452834","https://openalex.org/W2155075889","https://openalex.org/W2158873843","https://openalex.org/W2162772698","https://openalex.org/W2169561386","https://openalex.org/W2172198911","https://openalex.org/W2312642584","https://openalex.org/W2330047668","https://openalex.org/W4245200928"],"related_works":["https://openalex.org/W1977968341","https://openalex.org/W349195036","https://openalex.org/W2162457674","https://openalex.org/W2113700150","https://openalex.org/W2160711172","https://openalex.org/W2169561386","https://openalex.org/W1995364703","https://openalex.org/W2026630954","https://openalex.org/W2058931697","https://openalex.org/W2079517309"],"abstract_inverted_index":{"OBJECTIVE:":[0],"We":[1],"wished":[2],"to":[3,23,25,111,127,188],"assess,":[4],"in":[5,34,61,122,135,191,199],"heavily":[6],"treatment-experienced":[7,201],"patients,":[8],"the":[9],"prevalence":[10],"of":[11,38,45],"and":[12,20,43,56,59,83,108,168,179,182,203],"baseline":[13,52,118],"characteristics":[14],"associated":[15,91,154],"with":[16,92,103,117,155,165],"HIV-1":[17],"coreceptor":[18,53,62,119],"use":[19,63,198],"their":[21],"relationship":[22],"responses":[24,110,181],"enfuvirtide":[26,139,195],"treatment.":[27,65],"METHODS:":[28],"Samples":[29],"were":[30,47,69,90,132,153,169],"obtained":[31],"from":[32,125,186],"participants":[33],"phase":[35],"3":[36],"studies":[37],"enfuvirtide.":[39],"Multiple":[40],"logistic":[41],"regression":[42],"analysis":[44],"covariance":[46],"performed":[48],"on":[49],"data":[50],"for":[51,71,210],"use,":[54],"virological":[55,178],"immunological":[57,109,180],"response,":[58],"changes":[60],"during":[64,130],"RESULTS:":[66],"Baseline":[67],"envelopes":[68],"phenotyped":[70],"724":[72],"patients;":[73],"50%":[74],"harbored":[75,79,85],"R5":[76,104,128,166,189],"strains,":[77,82,167],"48%":[78],"dual/mixed":[80],"(D/M)":[81],"2%":[84],"X4":[86],"strains.":[87],"D/M":[88,126,151,187],"strains":[89,105,129,152,190],"significantly":[93],"lower":[94,156],"CD4(+)":[95,157,172],"cell":[96,158,173],"counts":[97,159],"but":[98,160],"comparable":[99,177],"viral":[100,162],"loads,":[101,163],"compared":[102,164],"(P=.0005).":[106],"Virological":[107],"enfuvirtide-based":[112],"treatment":[113,131],"showed":[114],"no":[115,145],"correlation":[116],"use.":[120],"Changes":[121],"virus":[123],"tropism":[124],"common,":[133],"particularly":[134],"patients":[136,192,202],"who":[137,143,193],"received":[138,144,194],"(27%,":[140],"vs.":[141],"14%":[142],"enfuvirtide;":[146],"P<.05).":[147],"CONCLUSION:":[148],"At":[149],"baseline,":[150],"similar":[161],"common":[170],"across":[171],"count":[174],"strata.":[175],"The":[176],"bias":[183],"toward":[184],"shifts":[185],"support":[196],"its":[197,204],"triple-class":[200],"study":[205],"as":[206],"a":[207],"therapeutic":[208],"partner":[209],"coreceptor-binding":[211],"inhibitors.":[212]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}